You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
旗濱集團(601636.SH):公司跟投平台對湖南藥玻進行增資 其建中性硼硅藥用玻璃素管生產線項目第一期
格隆匯 08-10 18:27

格隆匯 8 月 10日丨旗濱集團(601636.SH)公佈,公司第四屆董事會第十七次會議決議,審議並通過了《關於公司跟投平台對湖南旗濱醫藥材料科技有限公司增資暨關聯交易的議案》;

經公司第四屆董事會第七次會議、公司2019年第四次臨時股東大會批准,公司201912在湖南省郴州市資興市投資設立湖南旗濱醫藥材料科技有限公司(“湖南藥玻”),建設中性硼硅藥用玻璃素管生產線項目第一期(一期建設規模為25/天)湖南藥玻註冊資本人民幣1億元,其中公司跟投平台跟投資金3080萬元,持股30.80%

根據株洲旗濱集團股份有限公司項目跟投管理制度要求,同意公司跟投平台繼續以增資方式增加部分資金補充湖南藥玻跟投,同意公司制定的湖南旗濱醫藥材料科技有限公司2020年增資跟投方案。此次公司跟投平台(5家有限合夥企業)籌集跟投資金人民幣200萬元,按照1/註冊資本的價格對南藥玻進行增資。

增資後湖南藥玻的註冊資本由1億元增加至1.02億元,公司跟投平台對湖南藥玻持股比例30.80%增加至32.1569%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account